Summary
Details
- Initial counseling
- Barrier methods
- Barrier methods: the diaphragm and cervical cap
- Barrier methods: the female condom
- Barrier methods: the male condom
- Barrier methods: spermicide
- Behavioral methods
- Behavioral methods: lactational amenorrhea
- Behavioral methods: periodic abstinence
- Behavioral methods: withdrawal
- Hormonal contraception
- Combined hormonal contraceptives (estrogen/progestogen)
- Contraindications to estrogen-containing contraceptives
- Combined hormonal contraceptives: estrogen/progestogen pills
- Combined hormonal contraceptives: estrogen/progestogen patch
- Combined hormonal contraceptives: estrogen/progestogen vaginal ring
- Progestogen-only contraceptives
- Progestogen-only contraceptives: progestogen-only pill
- Progestogen-only contraceptives: progestogen implant
- Progestogen-only contraceptives: progestogen injection
- Non-hormonal contraception
- Intrauterine devices (IUDs)
- Intrauterine devices: copper IUD
- Intrauterine devices: progestogen IUD
- Sterilization
- Sterilization: female sterilization
- Sterilization: male sterilization
- Non-contraceptive benefits of hormonal contraceptives
- Emergency contraception
- Emergency contraception: progestogen-only emergency contraception
- Emergency contraception: ulipristal
- Emergency contraception: copper IUD
- Emergency contraception: estrogen/progestogen emergency contraception
- Guidelines
Colaboradores
Autores
Anne Burke, MD, MPH
Associate Professor
Johns Hopkins University
Baltimore
MD
Declarações
AB has received research support from Merck and Chemo.
Agradecimentos
Dr Anne Burke would like to gratefully acknowledge Dr Ruth Lesnewski, a previous contributor to this topic.
Declarações
RL declares that she has no competing interests.
Revisores
Larry Leeman, MD, MPH
Associate Professor of Family and Community Medicine
Associate Professor of Obstetrics and Gynecology
Family Medicine Department
University of New Mexico
Albuquerque
NM
Declarações
LL declares that he has no competing interests.
Suzan Goodman, MD, MPH
Director
TEACH Program
Assistant Clinical Professor
UCSF and UCD
San Francisco
CA
Declarações
SG has served as an Implanon training specialist for Organon Inc.
Lesley Bacon, FFSRH, MRCGP
Consultant in Sexual and Reproductive Health
Lewisham Primary Care Trust
Waldron Health Centre
London
UK
Declarações
LB was a member of the group that produced the 2006 Faculty of Sexual and Reproductive Health guidance on the management of women with vaginal discharge presenting in a non-genitourinary settings.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
Curtis KM, Nguyen AT, Tepper NK, et al. U.S. selected practice recommendations for contraceptive use, 2024. MMWR Recomm Rep 2024;73(3):1-77.Texto completo Resumo
The Faculty of Sexual & Reproductive Healthcare (FSRH) of the Royal College of Obstetricians & Gynaecologists. UK Medical Eligibility Criteria for contraceptive use (UKMEC). Sep 2019 [internet publication].Texto completo
World Health Organization. Medical Eligibility Criteria for contraceptive use (MEC). Fifth edition. Aug 2015 [internet publication].Texto completo Resumo
Nguyen AT, Curtis KM, Tepper NK, et al. U.S. medical eligibility criteria for contraceptive use, 2024. MMWR Recomm Rep 2024;73(4):1-126.Texto completo Resumo
Stewart FH, Harper CC, Ellertson CE, et al. Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence. JAMA. 2001 May 2;285(17):2232-9. Resumo
American College of Obstetricians and Gynecologists. Practice bulletin no. 186 summary: long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2017 Nov;130(5):1173-5. Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Folhetos informativos para os pacientes
Chlamydia
Genital warts
Mais Folhetos informativos para os pacientes
Conectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal